Report Detail
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Growth (Status and Outlook) 2019-2024
- RnM3380136 |
- 06 May, 2019 |
- Global |
- 138 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
According to this study, over the next five years the Cancer Immunotherapy Drug Discovery Outsourcing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Cancer Immunotherapy Drug Discovery Outsourcing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Cancer Immunotherapy Drug Discovery Outsourcing market by product type, application, key companies and key regions.
This study considers the Cancer Immunotherapy Drug Discovery Outsourcing value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Monoclonal Antibodies
Immunomodulators
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Lung
Breast
Colorectal
Melanoma
Prostate
Head and Neck
Ovarian
Pancreatic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Aquila BioMedical
BPS Bioscience, Inc.
Celentyx Ltd
Crown Bioscience, Inc.
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences Co.
Horizon Discovery Group PLC
ImmunXperts SA
Molecular Imaging, Inc.
Promega Corporation,Personalis, Inc.
STC Biologics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cancer Immunotherapy Drug Discovery Outsourcing market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cancer Immunotherapy Drug Discovery Outsourcing market by identifying its various subsegments.
Focuses on the key global Cancer Immunotherapy Drug Discovery Outsourcing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cancer Immunotherapy Drug Discovery Outsourcing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Cancer Immunotherapy Drug Discovery Outsourcing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2014-2024
- 2.1.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Size CAGR by Region
- 2.2 Cancer Immunotherapy Drug Discovery Outsourcing Segment by Type
- 2.2.1 Monoclonal Antibodies
- 2.2.2 Immunomodulators
- 2.2.3 Oncolytic Viral Therapies and Cancer Vaccines
- 2.2.4 Other
- 2.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
- 2.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type (2014-2019)
- 2.4 Cancer Immunotherapy Drug Discovery Outsourcing Segment by Application
- 2.4.1 Lung
- 2.4.2 Breast
- 2.4.3 Colorectal
- 2.4.4 Melanoma
- 2.4.5 Prostate
- 2.4.6 Head and Neck
- 2.4.7 Ovarian
- 2.4.8 Pancreatic
- 2.5 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
- 2.5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Application (2014-2019)
3 Global Cancer Immunotherapy Drug Discovery Outsourcing by Players
- 3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Players
- 3.1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Players (2017-2019)
- 3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Players (2017-2019)
- 3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Cancer Immunotherapy Drug Discovery Outsourcing by Regions
- 4.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions
- 4.2 Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth
- 4.3 APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth
- 4.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth
- 4.5 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth
5 Americas
- 5.1 Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Countries
- 5.2 Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
- 5.3 Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Countries
- 6.2 APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
- 6.3 APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing by Countries
- 7.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
- 7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing by Countries
- 8.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
- 8.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast
- 10.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast (2019-2024)
- 10.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Regions
- 10.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Type
- 10.8 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Application
11 Key Players Analysis
- 11.1 Aquila BioMedical
- 11.1.1 Company Details
- 11.1.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
- 11.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Aquila BioMedical News
- 11.2 BPS Bioscience, Inc.
- 11.2.1 Company Details
- 11.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
- 11.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 BPS Bioscience, Inc. News
- 11.3 Celentyx Ltd
- 11.3.1 Company Details
- 11.3.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
- 11.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Celentyx Ltd News
- 11.4 Crown Bioscience, Inc.
- 11.4.1 Company Details
- 11.4.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
- 11.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Crown Bioscience, Inc. News
- 11.5 DiscoverX Corporation
- 11.5.1 Company Details
- 11.5.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
- 11.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 DiscoverX Corporation News
- 11.6 Explicyte
- 11.6.1 Company Details
- 11.6.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
- 11.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Explicyte News
- 11.7 Genscript Biotech Corporation
- 11.7.1 Company Details
- 11.7.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
- 11.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Genscript Biotech Corporation News
- 11.8 HD Biosciences Co.
- 11.8.1 Company Details
- 11.8.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
- 11.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 HD Biosciences Co. News
- 11.9 Horizon Discovery Group PLC
- 11.9.1 Company Details
- 11.9.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
- 11.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Horizon Discovery Group PLC News
- 11.10 ImmunXperts SA
- 11.10.1 Company Details
- 11.10.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
- 11.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 ImmunXperts SA News
- 11.11 Molecular Imaging, Inc.
- 11.12 Promega Corporation,Personalis, Inc.
- 11.13 STC Biologics
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Cancer Immunotherapy Drug Discovery Outsourcing . Industry analysis & Market Report on Cancer Immunotherapy Drug Discovery Outsourcing is a syndicated market report, published as Global Cancer Immunotherapy Drug Discovery Outsourcing Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Cancer Immunotherapy Drug Discovery Outsourcing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
